VANCOUVER, June 22 /PRNewswire-FirstCall/ - Dragon Pharmaceutical Inc. ("Dragon Pharma" or the "Company" TSX: DDD; OTCBB: DRUG; BBSE: DRP), a leading international pharmaceutical company, today announced the results of the Annual Shareholders Meeting held on June 21, 2009 in Hong Kong, China.
There were 50,209,377 shares equaling 74.87% of the outstanding shares represented at this meeting. The shareholders re-elected the following eight persons to serve as members of the Board of Directors for the Company: Mr. Yanlin Han, Mr. Zhanguo Weng, Ms. Xuemei Liu, Dr. Alexander Wick, Ph.D., Dr. Yiu Kwong Sun, M.D., Mr. Peter Mak, Dr. Heinz Frey and Dr. Jin Li.
SOURCE Dragon Pharmaceutical Inc.